Table of Contents 3
List of Tables 5
List of Figures 5
Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ohio State University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10
Ohio State University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Ohio State University, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Iovance Biotherapeutics Enters into Research Agreement with Arthur G. James Cancer Hospital & Richard J Solove Research Institute 13
Exicure Enters into Agreement with Ohio State University 14
Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 15
Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 16
Evotec Enters into Research Agreement with Ohio State University 17
Imcare Biotech Enters into Development Partnership with Ohio State University 18
Ohio State University and University of Michigan Enter into Agreement with Venture Therapeutics 19
Ohio State University Enters Into Licensing Agreement With MedVax Technologies For Cancer Peptide Vaccine 20
Biosortia Pharma Enters into Research Agreement with Ohio State University 21
National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 22
Licensing Agreements 23
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 23
Ohio State Innovation Enters into Licensing Agreement with Therapeutics Company 24
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 25
Cellectis Enters into Licensing Agreement with Ohio State Innovation Foundation 26
The Ohio State University Enters Into Licensing Agreement With Microlin Bio 27
NewLink Genetics Enters into Licensing Agreement with Ohio State University 28
Rexahn Pharma Enters Into Licensing Agreement With Ohio State Innovation Foundation For Oligonucleotide Drug Delivery Platform 29
Asset Transactions 30
Aspen Park Pharma Acquires Worldwide Rights to APP-111 Therapy from Ohio State University 30
Ohio State University - Key Competitors 31
Ohio State University - Key Employees 32
Ohio State University - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Government and Public Interest 34
Aug 30, 2018: New program boosts use of HIV medications in injection-drug users 34
Aug 30, 2018: Research to examine how blood flow influences plaque buildup 36
May 31, 2018: Bonnie J. Addario Lung Cancer Foundation and Van Auken Private Foundation Announce the 2018 Young Innovators Team Award for Lung Cancer Research 38
Feb 26, 2018: National Colorectal Cancer Roundtable Recognizes Leaders in Colorectal Cancer Screening Efforts with 80% by 2018 National Achievement Award 39
Jan 23, 2018: Damon Runyon Cancer Research Foundation awards $3M to eleven innovative early career scientists 41
Dec 18, 2017: Tiny Bilirubin-filled Capsules Could Improve Survival of Transplanted Pancreatic Cells 44
Nov 30, 2017: Invasive cells in head and neck tumors predict cancer spread 45
Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 47
Sep 07, 2017: Gillings Innovation Lab Award Funds Hepatitis Prevention in Africa 48
Jun 08, 2017: Balance Gait Negatively Impacted After Chemotherapy Treatment 49
Jun 02, 2017: Drug Discovery and Development- "Immunotherapy: Training The Body to Fight Cancer" 51
May 15, 2017: Cure SMA Awards $75,000 Grant to Stephen J. Kolb, PhD, Ohio State University 52
May 15, 2017: $2.6 Million in New Grants Spurs Innovation 53
Product News 56
Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 56
Aug 06, 2018: Novel vaccine approach proves powerful against Zika virus 58
Other Significant Developments 60
Oct 16, 2018: A 150-year-old drug might improve radiation therapy for cancer 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Ohio State University, Pharmaceuticals & Healthcare, Key Facts 2
Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ohio State University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ohio State University, Deals By Therapy Area, 2012 to YTD 2018 9
Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10
Ohio State University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Iovance Biotherapeutics Enters into Research Agreement with Arthur G. James Cancer Hospital & Richard J Solove Research Institute 13
Exicure Enters into Agreement with Ohio State University 14
Biosortia Pharmaceuticals Enters into Collaboration with Ohio State University Comprehensive Cancer Center 15
Bristol-Myers Squibb Enters into Agreement with Ohio State University Comprehensive Cancer Center 16
Evotec Enters into Research Agreement with Ohio State University 17
Imcare Biotech Enters into Development Partnership with Ohio State University 18
Ohio State University and University of Michigan Enter into Agreement with Venture Therapeutics 19
Ohio State University Enters Into Licensing Agreement With MedVax Technologies For Cancer Peptide Vaccine 20
Biosortia Pharma Enters into Research Agreement with Ohio State University 21
National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 22
Imugene Enters into Licensing Agreement with Ohio State University Wexner Medical Center and Mayo Clinic 23
Ohio State Innovation Enters into Licensing Agreement with Therapeutics Company 24
Lattice Biotech Receives Rights to Anti-Infective Technology from University of Southern California, Ohio State University and Nationwide Children's Hospital 25
Cellectis Enters into Licensing Agreement with Ohio State Innovation Foundation 26
The Ohio State University Enters Into Licensing Agreement With Microlin Bio 27
NewLink Genetics Enters into Licensing Agreement with Ohio State University 28
Rexahn Pharma Enters Into Licensing Agreement With Ohio State Innovation Foundation For Oligonucleotide Drug Delivery Platform 29
Aspen Park Pharma Acquires Worldwide Rights to APP-111 Therapy from Ohio State University 30
Ohio State University, Key Competitors 31
Ohio State University, Key Employees 32
Ohio State University, Subsidiaries 33

List of Figures
Ohio State University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ohio State University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Ohio State University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Ohio State University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Ohio State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Ohio State University, Medical Devices Deals, 2012 to YTD 2018 10